Key TakeawaysLITE shares started Friday at $732.82, declining approximately 16% in the past month and 18% over three months despite a 3.8% daily rally following analyst upgradesThird quarter fiscal 2026 revenue reached $808.4 million, representing a 90.1% annual increase, while earnings per share of $2.37 exceeded projections by $0.10Fourth quarter 2026 EPS outlook ranges from $2.85 to $3.05; analysts predict full-year EPS of $6.42Wall Street consensus shows Moderate Buy sentiment with mean price objective at $1,012.67, representing significant upside from present levelsInstitutional shareholders control 94.05% of outstanding shares, with multiple new stakes initiated during the first quarter; company insiders offloaded $38.8 million in shares over the previous 90 daysShares of Lumentum Holdings (LITE) began trading Friday at $732.82, trading significantly beneath its 50-day moving average of $865.06, despite receiving multiple favorable analyst rating changes that drew renewed market focus.Lumentum Holdings Inc., LITEThe shares climbed 3.8% during a single trading day after these upgrades were announced, though this rally hasn’t been sufficient to reverse the broader downtrend. LITE remains approximately 16% lower over the past month and down 18% across the trailing three-month period.This decline occurred even after Lumentum delivered impressive quarterly results. During its third quarter of fiscal year 2026, the company reported revenues totaling $808.4 million, marking a 90.1% increase compared to the prior year. Earnings per share reached $2.37, surpassing the Street’s $2.27 expectation by $0.10.Looking ahead to the fourth quarter of 2026, management projects earnings per share between $2.85 and $3.05. The analyst community collectively anticipates full-year EPS of $6.42.Trading at a price-to-earnings multiple of 135.71x, the stock commands a substantial premium compared to the US Communications sector’s average of 31.7x. This valuation gap has become a focal point in ongoing investment discussions.Wall Street Projections Versus Market PriceAnalysts’ consensus price objective stands at $1,012.67, implying approximately 38% potential appreciation from today’s valuation. Among the 21 analysts tracking the company, 14 maintain Buy recommendations while seven assign Hold ratings.Stifel increased its price target from $800 to $1,100 while maintaining a Buy stance. Northland Securities established a $1,200 target with an Outperform designation. Jefferies similarly maintains a $1,200 objective. Citigroup reaffirmed its Buy recommendation Thursday and placed LITE on a 90-day catalyst monitoring list.Conversely, Zacks downgraded the stock from Strong Buy to Hold on July 6th, while UBS maintains its Hold position — representing contrarian perspectives amid predominantly optimistic coverage.One discounted cash flow analysis estimates intrinsic value at $1,026.15 based on projected cash generation. An alternative, more optimistic valuation framework suggests fair value near $5,085.95 — a figure dependent upon maintaining robust and prolonged revenue growth trajectories.Institution Accumulation Meets Insider DistributionInstitutional investors collectively hold 94.05% of Lumentum’s outstanding equity. During the first quarter, several new institutional positions emerged, including Freemont Management S.A. with $8.29 million, Mediolanum International Funds contributing $2.87 million, and Hanseatic Management Services establishing a $2.68 million stake.Meanwhile, corporate insiders have disposed of $38.8 million in shares during the previous 90-day window. Director Isaac Hosojiro Harris sold 1,416 shares at an average price of $1,000.08 on June 2nd through a predetermined Rule 10b5-1 trading arrangement. SVP Jae Kim divested 1,422 shares at $953.95 in May, with a portion sold to satisfy tax liabilities associated with vested equity compensation.Lumentum’s 52-week trading range spans from a low of $97.55 to a high of $1,085.68. The stock’s 200-day moving average currently rests at $710.76.The most recent analyst activity includes Citigroup’s addition of the stock to its 90-day catalyst watchlist.The post Lumentum (LITE) Stock Plummets 16% — Should Investors Buy the Dip? appeared first on Blockonomi.